Tislelizumab Biosimilar - Research Grade
Tislelizumab Biosimilar - Research Grade
Product Benefits:ichorbio's Tislelizumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility. Click here to view ichorbio’s complete list of anti-PD-1 antibodies and biosimilars.
Size:ichorbio's Tislelizumab biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our Tislelizumab biosimilar - please contact us for pricing.
Target:PD-1
Isotype:IgG4 kappa
Other Names:Programmed cell death protein 1, Pdcd1, CD279
Host:CHO cells
Species Reactivity:Human
Specificity:Detects human PD-1.
Purification Method:This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:Tislelizumab biosimilar is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. It is an IgG4 kappa immunoglobulin with an approximate molecular weight of 149 kDa.
Concentration:1.0 - 5.0 mg/ml
Formulation:Sterile, preservative-free, clear to milky white colorless to slightly yellow solution, containing L-histidine , polysorbate 80 and sucrose. pH set to 5.5. BSA and Azide free.
Purity:>95% by SDS-PAGE and HPLC
Endotoxin:≤ 0.75 EU/mg as determined by the LAL method
Storage:Tislelizumab Biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:Functional Assays
Application Notes:Each investigator should determine their own optimal working dilution for specific applications.
Isotype Control: Use: ichorbio's Tislelizumab biosimilar is for research use only (RUO).| Concentration | 9.48mg/ml |
|---|---|
| Isotype | IgG4 kappa |
| Host | CHO cells |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Application Notes | This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients. |
| Applications | Functional Assays |
| Storage | Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles. |
| Endotoxin | <1 EU/mg Determined by LAL gel clotting assay |
| Purity | >95% by SDS-PAGE and HPLC |
| Formulation | Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human PD-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Tislelizumab. |
| Species Reactivity | Human |
| Target | PD-1 |
| Shipping Conditions | Blue ice |
| background | Pembrolizumab biosimilar is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. It is an IgG4 kappa immunoglobulin with an approximate molecular weight of 149 kDa. |
| Other names | Programmed cell death protein 1, Pdcd1, CD279 |
| UniProt | Q15116 |
| Buffer | ICH3002 |
| Sequence | https://www.imgt.org/mAb-DB/ |